Bevacizumab and subtype-adapted chemotherapy backbone in neuroendocrine tumors.

Subjects

Subjects :

Female
Humans
Male
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Dacarbazine administration & dosage
Dacarbazine analogs & derivatives
Neuroendocrine Tumors drug therapy

Details

Language :

English

ISSN :

1527-7755

Volume :

31

Issue :

7

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

23358990

Full Text :

https://doi.org/10.1200/JCO.2012.47.0351